Citigroup’s Ionis Pharmaceuticals IONS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $1.43M | Hold |
18,000
| – | – | ﹤0.01% | 3186 |
|
|
2026
Q1 | $1.35M | Buy |
+18,000
| New | +$1.42M | ﹤0.01% | 2919 |
|
|
2025
Q2 | – | Sell |
-30,000
| Closed | -$905K | – | 5772 |
|
|
2025
Q1 | $905K | Buy |
30,000
+6,400
| +27% | +$210K | ﹤0.01% | 3318 |
|
|
2024
Q4 | $825K | Hold |
23,600
| – | – | ﹤0.01% | 3508 |
|
|
2024
Q3 | $945K | Buy |
+23,600
| New | +$1.1M | ﹤0.01% | 3305 |
|
|
2023
Q4 | – | Sell |
-27,500
| Closed | -$1.25M | – | 5772 |
|
|
2023
Q3 | $1.25M | Sell |
27,500
-29,800
| -52% | -$1.23M | ﹤0.01% | 2331 |
|
|
2023
Q2 | $2.35M | Hold |
57,300
| – | – | ﹤0.01% | 2056 |
|
|
2023
Q1 | $2.05M | Buy |
+57,300
| New | +$2.15M | ﹤0.01% | 2005 |
|
|
2022
Q4 | – | Sell |
-29,900
| Closed | -$1.32M | – | 5853 |
|
|
2022
Q3 | $1.32M | Buy |
+29,900
| New | +$1.26M | ﹤0.01% | 2489 |
|
|
2021
Q1 | – | Sell |
-26,000
| Closed | -$1.47M | – | 6809 |
|
|
2020
Q4 | $1.47M | Buy |
26,000
+4,200
| +19% | +$209K | ﹤0.01% | 3151 |
|
|
2020
Q3 | $1.03M | Sell |
21,800
-700
| -3% | -$38.9K | ﹤0.01% | 3246 |
|
|
2020
Q2 | $1.33M | Buy |
22,500
+7,700
| +52% | +$428K | ﹤0.01% | 3249 |
|
|
2020
Q1 | $700K | Sell |
14,800
-22,500
| -60% | -$1.25M | ﹤0.01% | 3543 |
|
|
2019
Q4 | $2.25M | Sell |
37,300
-40,800
| -52% | -$2.43M | ﹤0.01% | 2842 |
|
|
2019
Q3 | $4.68M | Buy |
78,100
+11,600
| +17% | +$756K | ﹤0.01% | 2007 |
|
|
2019
Q2 | $4.27M | Buy |
66,500
+12,600
| +23% | +$891K | ﹤0.01% | 2101 |
|
|
2019
Q1 | $4.38M | Buy |
53,900
+1,100
| +2% | +$71K | ﹤0.01% | 1914 |
|
|
2018
Q4 | $2.85M | Buy |
52,800
+19,400
| +58% | +$989K | ﹤0.01% | 2331 |
|
|
2018
Q3 | $1.72M | Sell |
33,400
-900
| -3% | -$42.3K | ﹤0.01% | 2896 |
|
|
2018
Q2 | $1.43M | Buy |
34,300
+100
| +0.3% | +$4.43K | ﹤0.01% | 3002 |
|
|
2018
Q1 | $1.51M | Sell |
34,200
-2,300
| -6% | -$117K | ﹤0.01% | 2863 |
|
|
2017
Q4 | $1.84M | Sell |
36,500
-11,700
| -24% | -$642K | ﹤0.01% | 2758 |
|
|
2017
Q3 | $2.44M | Sell |
48,200
-20,700
| -30% | -$1.08M | ﹤0.01% | 2446 |
|
|
2017
Q2 | $3.5M | Buy |
68,900
+24,300
| +54% | +$1.13M | ﹤0.01% | 2022 |
|
|
2017
Q1 | $1.79M | Sell |
44,600
-55,100
| -55% | -$2.47M | ﹤0.01% | 2600 |
|
|
2016
Q4 | $4.77M | Buy |
99,700
+7,400
| +8% | +$293K | ﹤0.01% | 1889 |
|
|
2016
Q3 | $3.38M | Buy |
92,300
+50,100
| +119% | +$1.57M | ﹤0.01% | 2029 |
|
|
2016
Q2 | $983K | Buy |
42,200
+5,800
| +16% | +$187K | ﹤0.01% | 2983 |
|
|
2016
Q1 | $1.47M | Sell |
36,400
-6,100
| -14% | -$248K | ﹤0.01% | 2880 |
|
|
2015
Q4 | $2.63M | Sell |
42,500
-23,700
| -36% | -$1.28M | ﹤0.01% | 2270 |
|
|
2015
Q3 | $2.68M | Buy |
66,200
+51,500
| +350% | +$2.67M | ﹤0.01% | 2202 |
|
|
2015
Q2 | $846K | Buy |
14,700
+2,500
| +20% | +$159K | ﹤0.01% | 3277 |
|
|
2015
Q1 | $777K | Buy |
+12,200
| New | +$828K | ﹤0.01% | 3320 |
|
Other funds holding IONS
Citigroup's IONS Position: Q2 2026 in Review
Citigroup reduced its Ionis Pharmaceuticals (IONS) stake by 41% in Q2 2026, selling an estimated $4.5M and leaving 86,746 shares worth $6.88M. The position accounts for ﹤0.01% of the portfolio, ranked #1879.
Citigroup first reported a position in IONS in Q2 2013 and has held it in 53 quarters since. The position peaked at $13.5M in Q2 2025. 514 funds tracked by Wall St. Rank hold IONS as of Q2 2026.
- Citigroup held 86,746 shares of Ionis Pharmaceuticals worth $6.88M as of Q2 2026.
- Citigroup sold 59,795 Ionis Pharmaceuticals shares in Q2 2026, an estimated $4.5M.
- Ionis Pharmaceuticals made up ﹤0.01% of Citigroup's portfolio in Q2 2026, its #1879 holding.
- Citigroup first reported a position in Ionis Pharmaceuticals in Q2 2013 and has held it in 53 quarters since.
- Citigroup's Ionis Pharmaceuticals position peaked at $13.5M in Q2 2025.
- 514 funds tracked by Wall St. Rank held Ionis Pharmaceuticals as of Q2 2026.
Based on Citigroup's 13F filing for Q2 2026, filed 3 Aug 2026.